Cargando…
Erratum. Effect of Losartan on Prevention and Progression of Early Diabetic Nephropathy in American Indians With Type 2 Diabetes. Diabetes 2013;62:3224–3231
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5828456/ https://www.ncbi.nlm.nih.gov/pubmed/29305527 http://dx.doi.org/10.2337/db18-er03a |
_version_ | 1783302650357350400 |
---|---|
author | Weil, E. Jennifer Fufaa, Gudeta Jones, Lois I. Lovato, Tracy Lemley, Kevin V. Hanson, Robert L. Knowler, William C. Bennett, Peter H. Yee, Berne Myers, Bryan D. Nelson, Robert G. |
author_facet | Weil, E. Jennifer Fufaa, Gudeta Jones, Lois I. Lovato, Tracy Lemley, Kevin V. Hanson, Robert L. Knowler, William C. Bennett, Peter H. Yee, Berne Myers, Bryan D. Nelson, Robert G. |
author_sort | Weil, E. Jennifer |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-5828456 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | American Diabetes Association |
record_format | MEDLINE/PubMed |
spelling | pubmed-58284562018-03-01 Erratum. Effect of Losartan on Prevention and Progression of Early Diabetic Nephropathy in American Indians With Type 2 Diabetes. Diabetes 2013;62:3224–3231 Weil, E. Jennifer Fufaa, Gudeta Jones, Lois I. Lovato, Tracy Lemley, Kevin V. Hanson, Robert L. Knowler, William C. Bennett, Peter H. Yee, Berne Myers, Bryan D. Nelson, Robert G. Diabetes Errata American Diabetes Association 2018-03 2018-01-05 /pmc/articles/PMC5828456/ /pubmed/29305527 http://dx.doi.org/10.2337/db18-er03a Text en © 2018 by the American Diabetes Association. http://www.diabetesjournals.org/content/licenseReaders may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at http://www.diabetesjournals.org/content/license. |
spellingShingle | Errata Weil, E. Jennifer Fufaa, Gudeta Jones, Lois I. Lovato, Tracy Lemley, Kevin V. Hanson, Robert L. Knowler, William C. Bennett, Peter H. Yee, Berne Myers, Bryan D. Nelson, Robert G. Erratum. Effect of Losartan on Prevention and Progression of Early Diabetic Nephropathy in American Indians With Type 2 Diabetes. Diabetes 2013;62:3224–3231 |
title | Erratum. Effect of Losartan on Prevention and Progression of Early Diabetic Nephropathy in American Indians With Type 2 Diabetes. Diabetes 2013;62:3224–3231 |
title_full | Erratum. Effect of Losartan on Prevention and Progression of Early Diabetic Nephropathy in American Indians With Type 2 Diabetes. Diabetes 2013;62:3224–3231 |
title_fullStr | Erratum. Effect of Losartan on Prevention and Progression of Early Diabetic Nephropathy in American Indians With Type 2 Diabetes. Diabetes 2013;62:3224–3231 |
title_full_unstemmed | Erratum. Effect of Losartan on Prevention and Progression of Early Diabetic Nephropathy in American Indians With Type 2 Diabetes. Diabetes 2013;62:3224–3231 |
title_short | Erratum. Effect of Losartan on Prevention and Progression of Early Diabetic Nephropathy in American Indians With Type 2 Diabetes. Diabetes 2013;62:3224–3231 |
title_sort | erratum. effect of losartan on prevention and progression of early diabetic nephropathy in american indians with type 2 diabetes. diabetes 2013;62:3224–3231 |
topic | Errata |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5828456/ https://www.ncbi.nlm.nih.gov/pubmed/29305527 http://dx.doi.org/10.2337/db18-er03a |
work_keys_str_mv | AT weilejennifer erratumeffectoflosartanonpreventionandprogressionofearlydiabeticnephropathyinamericanindianswithtype2diabetesdiabetes20136232243231 AT fufaagudeta erratumeffectoflosartanonpreventionandprogressionofearlydiabeticnephropathyinamericanindianswithtype2diabetesdiabetes20136232243231 AT jonesloisi erratumeffectoflosartanonpreventionandprogressionofearlydiabeticnephropathyinamericanindianswithtype2diabetesdiabetes20136232243231 AT lovatotracy erratumeffectoflosartanonpreventionandprogressionofearlydiabeticnephropathyinamericanindianswithtype2diabetesdiabetes20136232243231 AT lemleykevinv erratumeffectoflosartanonpreventionandprogressionofearlydiabeticnephropathyinamericanindianswithtype2diabetesdiabetes20136232243231 AT hansonrobertl erratumeffectoflosartanonpreventionandprogressionofearlydiabeticnephropathyinamericanindianswithtype2diabetesdiabetes20136232243231 AT knowlerwilliamc erratumeffectoflosartanonpreventionandprogressionofearlydiabeticnephropathyinamericanindianswithtype2diabetesdiabetes20136232243231 AT bennettpeterh erratumeffectoflosartanonpreventionandprogressionofearlydiabeticnephropathyinamericanindianswithtype2diabetesdiabetes20136232243231 AT yeeberne erratumeffectoflosartanonpreventionandprogressionofearlydiabeticnephropathyinamericanindianswithtype2diabetesdiabetes20136232243231 AT myersbryand erratumeffectoflosartanonpreventionandprogressionofearlydiabeticnephropathyinamericanindianswithtype2diabetesdiabetes20136232243231 AT nelsonrobertg erratumeffectoflosartanonpreventionandprogressionofearlydiabeticnephropathyinamericanindianswithtype2diabetesdiabetes20136232243231 |